Wagner Mark T. - 28 Jun 2021 Form 4 Insider Report for Miromatrix Medical Inc.

Role
Director
Signature
/s/ Elise B. Houser, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jun 2021
Net transactions value
$0
Form type
4
Filing time
29 Jun 2021, 18:02:09 UTC
Previous filing
23 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRO Common Stock Conversion of derivative security +3,334 3,334 28 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRO Series B-2 Preferred Stock Conversion of derivative security -3,334 -100% 0 28 Jun 2021 Common Stock 3,334 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B-2 Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.